Predicting factors of echocardiographic super-response to cardiac resynchronization therapy
- PMID: 36367352
- DOI: 10.1002/jcu.23380
Predicting factors of echocardiographic super-response to cardiac resynchronization therapy
Abstract
Purpose: To investigate the clinical and echocardiographic predictors of echocardiographic super-response to cardiac resynchronization therapy (CRT) in heart failure patients.
Methods: We retrospectively collected data from 97 patients, who underwent CRT and were followed up (median time = 20.33 months). All had left ventricular ejection fraction (LVEF) ≤35%, New-York-Heart-Association class 3 or 4, and Q wave, R wave and S wave (QRS) duration >120 ms. Time-to-peak systolic velocity was measured for individual LV segments by tissue Doppler imaging prior to CRT. Two-dimensional echocardiography was carried out before and at follow-up, and ≥12.5% increase in LVEF was defined as super-response.
Results: From the 97 patients, 23 (23.7%) were super-responders. Super-responders were more frequently female (52.2% vs. 24.3%, respectively; p value = 0.012). Among super-responders, the mean of LV end-diastolic and end-systolic volumes were significantly lower. According to dyssynchrony indices, time delay between anteroseptal and posterior wall and SD of all LV segments timing showed significantly higher values in super-responders. By multivariate analysis, LV end-systolic volume and anteroseptal-to-posterior wall delay remained independently associated with echocardiographic super-response to CRT.
Conclusion: About one-fourth of our patients with CRT were super-responder in that they had ≥12.5% increase in LVEF by echocardiography. Among all the clinical and echocardiographic measures, only lower LV end-systolic volume and higher anteroseptal-to-posterior wall delay predicted super-response.
Keywords: cardiac resynchronization therapy; echocardiography; response; tissue Doppler imaging.
© 2022 Wiley Periodicals LLC.
Comment in
-
Prediction of a super-response to cardiac resynchronization therapy as guided by left ventricular end-systolic volume size.J Clin Ultrasound. 2023 Mar;51(3):394-397. doi: 10.1002/jcu.23393. J Clin Ultrasound. 2023. PMID: 36893040 No abstract available.
References
REFERENCES
-
- Glikson M, Nielsen JC, Kronborg MB, et al. ESC guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the task force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) with the special contribution of the European Heart Rhythm Association (EHRA). Rev Esp Cardiol. 2021;2022(75):430. doi:10.1016/j.rec.2022.04.004
-
- Sadeghian H, Lotfi-Tokaldany M, Montazeri M, et al. Early improvement in mitral regurgitation after cardiac resynchronization therapy in cardiomyopathy patients. J Heart Valve Dis. 2017;26:557-563.
-
- Ellenbogen KA, Huizar JF. Foreseeing super-response to cardiac resynchronization therapy: a perspective for clinicians. J Am Coll Cardiol. 2012;59:2374-2377.
-
- Hsu JC, Solomon SD, Bourgoun M, et al. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol. 2012;59:2366-2373.
-
- Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Am Soc Echocardiogr. 2015;28:1-39.e14.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials